RU2006134031A - Способ оценки терапевтического потенциала вакцины для введения через слизистые оболочки - Google Patents

Способ оценки терапевтического потенциала вакцины для введения через слизистые оболочки Download PDF

Info

Publication number
RU2006134031A
RU2006134031A RU2006134031/15A RU2006134031A RU2006134031A RU 2006134031 A RU2006134031 A RU 2006134031A RU 2006134031/15 A RU2006134031/15 A RU 2006134031/15A RU 2006134031 A RU2006134031 A RU 2006134031A RU 2006134031 A RU2006134031 A RU 2006134031A
Authority
RU
Russia
Prior art keywords
weeks
level
solid phase
ige
antibody
Prior art date
Application number
RU2006134031/15A
Other languages
English (en)
Russian (ru)
Inventor
Ханс-Хенрик ИПСЕН (DK)
Ханс-Хенрик ИПСЕН
МЕРКЕДАХЛ Лисе ЛУНД (DK)
МЕРКЕДАХЛ Лисе ЛУНД
Хенрик Хуго ЯКОБИ (DK)
Хенрик Хуго Якоби
Original Assignee
Альк-Абелло А/С (Dk)
Альк-Абелло А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Альк-Абелло А/С (Dk), Альк-Абелло А/С filed Critical Альк-Абелло А/С (Dk)
Publication of RU2006134031A publication Critical patent/RU2006134031A/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
RU2006134031/15A 2004-02-26 2005-02-24 Способ оценки терапевтического потенциала вакцины для введения через слизистые оболочки RU2006134031A (ru)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US54845404P 2004-02-26 2004-02-26
US60/548,454 2004-02-26
DKPA200400310 2004-02-26
DKPA200400310 2004-02-26
US55909504P 2004-04-02 2004-04-02
US60/559,095 2004-04-02
PCT/DK2005/000123 WO2005083385A2 (fr) 2004-02-26 2005-02-24 Procede pour evaluer le potentiel therapeutique d'un vaccin a administration mucosale

Publications (1)

Publication Number Publication Date
RU2006134031A true RU2006134031A (ru) 2008-04-10

Family

ID=34915878

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006134031/15A RU2006134031A (ru) 2004-02-26 2005-02-24 Способ оценки терапевтического потенциала вакцины для введения через слизистые оболочки

Country Status (8)

Country Link
EP (1) EP1718974A2 (fr)
JP (1) JP2007524096A (fr)
AU (1) AU2005217696B2 (fr)
BR (1) BRPI0508078A (fr)
CA (1) CA2556557A1 (fr)
IL (1) IL177703A0 (fr)
RU (1) RU2006134031A (fr)
WO (1) WO2005083385A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2006134031A (ru) * 2004-02-26 2008-04-10 Альк-Абелло А/С (Dk) Способ оценки терапевтического потенциала вакцины для введения через слизистые оболочки
AU2008231722B2 (en) * 2007-03-28 2013-09-12 Alk-Abello A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
ES2370043T3 (es) 2007-03-28 2011-12-12 Alk-Abelló A/S Uso de una formulación de vacuna de la alergia coadyuvada para administración subcutánea.
DE202008006598U1 (de) * 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
JP7062291B2 (ja) 2016-05-13 2022-05-16 応用酵素医学研究所株式会社 アレルギー発症リスクを予測するためのデータを収集する方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05508220A (ja) * 1991-05-10 1993-11-18 ドゥ・ウエック、アラン 抗ＩｇＥ自己抗体の検出および調製法およびこれら抗体の診断および治療組成物中での活性剤としての使用
US7888458B1 (en) * 1993-11-30 2011-02-15 John B. Harley Diagnostics and therapy of epstein-barr virus in autoimmune disorders
JP4523156B2 (ja) * 1998-06-24 2010-08-11 アルク−アベル・アー／エス 液体試料中における抗体の検出方法
AU1960100A (en) * 1999-01-06 2000-07-24 Mcmaster University Method of preventing immune and hypersensitivity reactions
SE0004892D0 (sv) * 2000-12-29 2000-12-29 Pharmacia Diagnostics Ab Group 2 allergen specific IgE-Fabs and use thereof
GB0215710D0 (en) * 2002-07-05 2002-08-14 Isis Innovation Diagnostic method
UA62780A (en) * 2003-05-22 2003-12-15 Univ Oo Bohomolets Nat Medical Method for estimating efficiency of vaccination against diphtheria in children with allergic diathesis
RU2006134031A (ru) * 2004-02-26 2008-04-10 Альк-Абелло А/С (Dk) Способ оценки терапевтического потенциала вакцины для введения через слизистые оболочки

Also Published As

Publication number Publication date
EP1718974A2 (fr) 2006-11-08
WO2005083385A2 (fr) 2005-09-09
AU2005217696A1 (en) 2005-09-09
IL177703A0 (en) 2006-12-31
AU2005217696B2 (en) 2008-02-14
JP2007524096A (ja) 2007-08-23
BRPI0508078A (pt) 2007-07-17
WO2005083385A3 (fr) 2005-11-17
CA2556557A1 (fr) 2005-09-09

Similar Documents

Publication Publication Date Title
US11241395B2 (en) Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease
JP6553020B2 (ja) アレルギー及び自己免疫疾患に関する診断分析を行うための自動化された免疫分析計システム
CN102105794B (zh) 移植物衰竭和死亡的标志物
ES2563049T3 (es) Método para la medida de ecuol en muestra biológica mediante inmunoensayo, kit para la medida, y método para la determinación de la capacidad de un sujeto para producir ecuol
RU2006134031A (ru) Способ оценки терапевтического потенциала вакцины для введения через слизистые оболочки
CN105785016A (zh) 基于pg磁微粒的双标记时间分辨荧光免疫分析试剂盒
JP2007524096A5 (fr)
JP4523156B2 (ja) 液体試料中における抗体の検出方法
CN106460056A (zh) 新型试样内检测对象物的检测方法及利用其的检测试剂盒
JP2009536327A (ja) 薬剤誘導肝臓損傷及び中毒性物質誘導肝臓損傷の同定及び早期同定並びに治療の同時観察のためのｉｎｖｉｔｒｏ方法
CN1098460C (zh) 抗体生产的检测
US20070224654A1 (en) Method of detecting an antibody in a liquid sample
Yao et al. Determination of salivary cortisol by nonisotopic immunoassay
WO2010097630A1 (fr) Biomarqueurs
Kiilerich et al. Neonatal inflammation, stress and growth factors after vaginal delivery, pre-labour, and in-labour caesarean section: a retrospective cohort study
Breesam et al. Evaluation of the Immunochromatography Assay's Diagnostic Performance for Quickly Detecting the Presence of COVID-19 Antigen in Patients with Positive PCR Results
JP2009014695A (ja) タイプｉｖコラーゲンｎｃ１測定キット
CN105154400B (zh) 多克隆抗乙肝病毒免疫细胞的扩增方法
JPH1087621A (ja) ルシゲニン化学発光の増強剤
Ugochukwu et al. REFERENCE VALUES OF HEPCIDIN AMONG HEALTHY CHILDREN IN UMUAHIA, SOUTH-EASTERN NIGERIA
JP2023073582A (ja) ＳＡＲＳ－ＣｏＶ－２感染症の予後判定補助方法
CN110579605A (zh) 一种快速分离免疫磁珠的方法
JP2022520931A (ja) 夜尿症の患者の治療応答を予測する方法
CN117502368A (zh) 一种psd大鼠模型的构建方法

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20100112